Pharmalink hires Cook and Poszepczynski as directors
This article was originally published in Scrip
Executive Summary
Pharmalink, a Swedish pharmaceutical company developing products for niche indications, has appointed Dr Heather Cook director of regulatory affairs, and Marek Poszepczynski director of business development. Dr Cook previously served as head of department for regulatory development projects at Lundbeck, while Mr Poszepczynski was most recently lead equity analyst at Handelsbanken covering European and Swedish biotechnology stocks.